Sumatriptan iontophoretic transdermal system with acute migraine.

Tuesday, November 5th, 2013 - 2:13 pm

The sumatriptan iontophoretic transdermal system (ZECUITY(®)) [hereafter referred to as sumatriptan TDS] is the first transdermal treatment for migraine to be approved by the US FDA. This system should prove useful to those migraine sufferers who have associated nausea and vomiting.

For more details on the system please Click here

Be Sociable, Share!